Global Soft Tissue Repair Procedures Market $11.6 Billion by 2029

The global market for soft tissue repair procedures projected to reach $11.6 billion by 2029, growing at a CAGR of 6.2% over the forecast period, driven by increasing number of sports injuries, as well as growing elderly population worldwide.

• The market is driven by technological advancements in the shoulder and rotator cuff procedures, innovative product offerings, increasing incidence of soft tissue injuries both in earlier interventions and later-stage revisions, increasing participation in sports and the increasing obesity rate across the world.

Soft tissue repair products are used to repair and reconstruct soft tissue injuries. Soft tissue surgeries are primarily aimed at improving joint stability by repairing the functional length of muscles, tendons, and ligaments.

• Common soft-tissue surgeries of the lower extremity include tendon transfers, muscle repairs, fasciotomies, cartilage resections or repairs, and ligament reconstructions.
• Soft tissue surgery encompasses any surgery relating to the skin. It includes procedures such as lump removals and reconstructions.
  • Many of soft tissue repair surgeries are performed arthroscopically in an ambulatory surgery setting.
    • Each year more than 1.6 million patients undergo surgeries for the repair of tendons, ligaments and cartilage in the shoulder, knee and ankles. The lack of efficacy of some of past offerings in soft tissue repair has created a pent-up demand for new treatment tools.

The global soft tissue repair procedures market report provides market size estimates ($million 2019 to 2029), market share, growth trends and forecast (CAGR% 2023 to 2029).

The global market for orthopedic soft tissue repair procedures segmented by type (achilles tendinosis repair, anterior cruciate ligament reconstruction, gluteal tendon or trochanteric bursitis repair, lateral epicondylitis, rotator cuff repair, and vaginal prolapse), and geography.

• The market for soft tissue repair procedures includes anterior and posterior cruciate ligament reconstruction and fixation products, cartilage repair therapies, meniscal repair devices, rotator cuff repair devices, shoulder and labrum repair devices, rotator cuff graft reinforcement devices, hip arthroscopy devices, and bicep tenodesis devices.
• Based on procedure type, the anterior cruciate ligament (ACL) reconstruction segment accounted for the largest share of the total market, and also anticipated to witness the fastest growth rate during the coming years.
  • Anterior cruciate ligament repair and/or reconstruction is one of the most common procedures in sports medicine. The incidence of knee osteoarthritis (OA) increases to between approximately 15% and 20% after an ACL tear, which represents a ten-fold increase.
    • It is suggested that more than 50% of patients that sustain an ACL injury will develop symptomatic OA in the following 10 to 20 years.
  • There has been a recent resurgence in interest with regards to primary ACL repair. Improvements in imaging now allow for identification of tear location, with femoral-sided injuries, being more suitable for repair.
    • Several promising avenues of further research now exist in the form of mechanical and biological augmentation techniques. 
  • According to the American Orthopedic Society of Sport Medicine (AOSSM), around 150,000 ACL injuries occur in the U.S. each year and the number is projected to increase in the near future.
• Overall, the procedures for orthopedic soft tissue repairs continue to grow and, coupled with product innovation, will drive up market value in the near future.
  • Many existing products, including all-suture anchors, cortical fixation devices and hybrid meniscal repair devices, will help fuel the market growth during the forecast period.
• As the healthcare market changes, more suppliers are investing in trials to demonstrate both clinical and economic differentiation.
  • Recent clinical evidence supporting polyetheretherketone (PEEK) and biocomposite anchors has allowed manufacturers to show growth with these products.

The global market for soft tissue repair procedures further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA) and Rest of the World.

• Geographically, the North America region dominated the use of soft tissue repair devices with more than two thirds of the total procedures worldwide.
  • Orthopedic soft tissue repair procedures are the second most leading and common ambulatory invasive, therapeutic surgeries performed in community hospitals in the United States.
    • In the U.S., the economic impact of these devices is minimal. The Affordable Care Act (ACA) may increase the pricing pressure.
      • As hospitals are under increasing pressures to reduce cost and increase clinical outcomes, the projected increase in procedural volume will be minimized by continued decreasing implant prices.

The global market research report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and/or services offered, and recent trends in strategic management.

Major competitors operating in the global market for soft tissue repair procedures and included in this report are Arthrex, Inc., ArthroCare Corporation, CONMED Corporation, Johnson & Johnson (DePuy Synthes, Inc.), Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings, Inc.

• Procedure
  • Achilles Tendinosis Repair
  • Anterior Cruciate Ligament (ACL) Reconstruction
  • Gluteal Tendon / Trochanteric Bursitis Repair
  • Lateral Epicondylitis
  • Rotator Cuff Repair
  • Vaginal Prolapse
• Geography
  • North America (U.S., Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
  • Asia Pacific (Japan, China, India, Rest of APAC)
  • Latin America (Brazil, Mexico, Rest of LA)
  • Rest of the World
• Company Profiles
  • Arthrex, Inc.
  • ArthroCare Corporation
  • CONMED Corporation
  • Johnson & Johnson (DePuy Synthes, Inc.)
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/orthopedic-soft-tissue-repair-market/

Related publications:

• Global Soft Tissue Regeneration and Repair Devices Market $9.6 Billion by 2029
• Soft Tissue Regeneration and Repair Devices Market by Product [Surgical Procedure Devices (Arthroscopes), Implantable Joint Prostheses (Implantable Joint Fixation Devices), Biologic Soft Tissue Regenerative Medicine and Repair Devices (Biologic Cartilage Regeneration and Repair Devices, Biologic Tendon/Ligament Regeneration and Repair Devices, Biologic Meniscus Regeneration and Repair Devices)] and Forecast 2023-2029
• Anterior Cruciate Ligament Repair Devices Market by Product [Knee Arthroscopy Products (Artificial Knee Joint Implants, Arthroscopic Visualization Products, Fluid Management Products, Manual Arthroscopy Instruments, Powered Arthroscopy Instruments), Soft Tissue Fixation Products (ACL Fixation Devices, Orthobiologics), ACL Support Products (Internal Braces, Accessories)] and Forecast 2023-2029
• Soft Tissue Repair Procedures Market by Type (Achilles Tendinosis Repair, Anterior Cruciate Ligament Reconstruction, Gluteal Tendon or Trochanteric Bursitis Repair, Lateral Epicondylitis, Rotator Cuff Repair, and Vaginal Prolapse) and Forecast 2023-2029
• Global Medical Devices Outsourcing Market $100.5 Billion by 2029